CASP9 and prostate cancer: Given that apoptosis can also be induced in human prostate cancer cells via the interaction of Fas and FasL [34, 35], we examined the involvement of this pathway in the augmented, caspase-8-dependent apoptosis of PC3 cells co-treated with ABT-263 and the caspase-9 inhibitor.